Inventiva Financials - Benzinga

Inventiva SA

IVANASDAQ

Trade with Public

Trade with Public

$3.37

0.113.37%

近くで: Sep 25, 5:00 PM EST

$3.34

-0.03-0.89%

時間外: 7:21 PM EST

決算:

決算説明会: 明日8:00 午前に電話会議が予定されています。

クリックしてウェブキャストを見る

概要ニュース業績予想イベント目標株価財務センチメント比較オプション株式レポート

Inventiva Financials

Inventiva (IVA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Earnings Scheduled For September 25, 2026

Companies Reporting Before The Bell • Tamboran Resources (NYSE:TBN) is estimated to report quarterly loss at $0.30 per share on revenue of $3.82 million. Companies Reporting After The Bell • Inventiva (NASDAQ:IVA) is

Benzinga Insights

PRO
Inventiva Reports No Revenue During H1, Compared To €4.5M YoY

Inventiva (Euronext Paris and NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic

Benzinga Newsdesk

PRO
Inventiva FY EPS $(2.14) Misses $(1.66) Estimate, Sales $5.064M Miss $6.000M Estimate

Inventiva (NASDAQ:IVA) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(1.66) by 28.92 percent. This is a 35.74 percent increase over losses of $(3.33) per share from the

Benzinga Newsdesk

Earnings Scheduled For March 30, 2026

Benzinga Insights

Earnings Scheduled For September 29, 2025

Companies Reporting Before The Bell • Inventiva (NASDAQ: IVA) is projected to report quarterly loss at $0.41 per share on revenue of $5.31 million. • Uxin (NASDAQ: UXIN) is estimated to report earnings for its second quarter.

Benzinga Insights

PRO
Inventiva H1 EPS $(1.84) Misses $(0.41) Estimate, Sales $5.050M Miss $5.310M Estimate

Inventiva (NASDAQ: IVA) reported quarterly losses of $(1.84) per share which missed the analyst consensus estimate of $(0.41) by 348.05 percent. This is a 81.88 percent decrease over losses of $(1.01) per share from the same period last year.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved